Trials / Completed
CompletedNCT00929994
Effects of Cardiac Rehabilitation for Individuals With Transient Ischemic Attack
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 20 (actual)
- Sponsor
- Toronto Rehabilitation Institute · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
It is hypothesized that the addition of formal cardiac rehabilitation to standard care will result in long-term improvements in cardiovascular fitness and functional capacity in individuals who have suffered a transient ischemic attack (TIA) or minor stroke. Furthermore, it is proposed that the addition of cardiac rehabilitation will influence depressive symptoms and cognition.
Detailed description
A transient ischemic attack (TIA) is defined as an episode of neurological dysfunction caused by focal brain ischemia lasting less than 24 hours. Once an individual has suffered a TIA, preventative measures can be taken to target modifiable risk factors, one of which is physical inactivity. The current proposal focuses on the use of an established model of care (cardiac rehabilitation (CR)) and applies it to those who have suffered a TIA in order to maximize physical activity and minimize risk of future cardiovascular events. This will be a one-group pre/post design study with a 3 month non-intervention period. Participants will undergo measures at baseline and 3 months (non intervention period) then after 6 months of cardiac rehabilitation (cardiovascular fitness, 6 minute walk test, cognition, and depressive symptoms).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Cardiac Rehabilitation | Individualized cardiac rehabilitation for 6 months, including health education sessions, as well as supervised exercise classes which include aerobic and resistance training. |
Timeline
- Start date
- 2010-03-01
- Primary completion
- 2014-11-01
- Completion
- 2014-11-01
- First posted
- 2009-06-30
- Last updated
- 2019-04-23
- Results posted
- 2019-04-23
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00929994. Inclusion in this directory is not an endorsement.